GE

231.8

+1.12%↑

RTX

135.35

-0.13%↓

CAT

353.49

+1.06%↑

BA

205.84

-0.2%↓

HON

222.76

+0.22%↑

GE

231.8

+1.12%↑

RTX

135.35

-0.13%↓

CAT

353.49

+1.06%↑

BA

205.84

-0.2%↓

HON

222.76

+0.22%↑

GE

231.8

+1.12%↑

RTX

135.35

-0.13%↓

CAT

353.49

+1.06%↑

BA

205.84

-0.2%↓

HON

222.76

+0.22%↑

GE

231.8

+1.12%↑

RTX

135.35

-0.13%↓

CAT

353.49

+1.06%↑

BA

205.84

-0.2%↓

HON

222.76

+0.22%↑

GE

231.8

+1.12%↑

RTX

135.35

-0.13%↓

CAT

353.49

+1.06%↑

BA

205.84

-0.2%↓

HON

222.76

+0.22%↑

Search

Enovis Corp

Fermé

SecteurIndustrie

36.1 0.98

Résumé

Variation du prix de l'action

24h

Actuel

Min

35.03

Max

36.14

Chiffres clés

By Trading Economics

Revenu

647M

-56M

Ventes

-2.1M

559M

BPA

0.81

Marge bénéficiaire

-9.968

Employés

7,367

EBITDA

535M

-56M

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+57.76% upside

Dividendes

By Dow Jones

Prochains Résultats

6 août 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-372M

2.1B

Ouverture précédente

35.12

Clôture précédente

36.1

Sentiment de l'Actualité

By Acuity

41%

59%

165 / 466 Classement par Industrials

Enovis Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

7 janv. 2025, 23:28 UTC

Principaux Mouvements du Marché

Maplebear Up on S&P MidCap 400 Inclusion

Comparaison

Variation de prix

Enovis Corp prévision

Objectif de Prix

By TipRanks

57.76% hausse

Prévisions sur 12 Mois

Moyen 57.14 USD  57.76%

Haut 75 USD

Bas 37 USD

Basé sur 8 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

8 ratings

7

Achat

1

Maintien

0

Vente

Sentiment

By Acuity

165 / 466Classement par Industrie

Sentiment de l'Actualité

Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Moyen

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Enovis Corp

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.